Stay updated on Pembrolizumab CNS Metastases Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab CNS Metastases Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to the Phase II clinical trial of Pembrolizumab as a potential treatment for central nervous system metastases from multiple histologies.
    Difference
    0.1%
    Check dated 2024-06-06T14:26:03.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to a detailed description of eligibility criteria, explaining that researchers look for participants who meet specific health conditions or prior treatments. This change provides more context and examples of the criteria used to select participants for clinical research.
    Difference
    55%
    Check dated 2024-05-22T21:18:33.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:33:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab CNS Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.